Abstract 1326: Magnetization Transfer MRI in Pancreatic Cancer Xenograft Models

Weiguo Li,Zhuoli Zhang,Jodi Nicolai,Guang-Yu Yang,Reed Omary,Andrew Larson

DOI: https://doi.org/10.1158/1538-7445.am2012-1326

IF: 11.2

2012-01-01

Cancer Research

Abstract:Abstract Tumor desmoplasia is a common hallmark of pancreatic ductal adenocarcinoma (PDAC), the 4th leading cause of cancer-related mortality. Recent studies clearly indicate that desmoplasia actively facilitates disease progression, metastasis, and drug resistance. Precise quantification of tumor fibrosis levels in PDAC may be critically important for patient staging and for the prediction or monitoring of responses to therapy. The current gold-standard for characterizing desmoplasia_histologic analysis of biopsy samples_is invasive and cannot avoid misrepresentation by reason of sampling error. Therefore, new methods to permit noninvasive quantification of fibrosis levels in PDAC would be particularly useful. Magnetization transfer (MT) MRI can be used to non-invasively probe dynamic physical processes involving the exchange of magnetization between sub-populations of free water protons and those water protons bound to tissue macromolecules. MT-MRI studies have demonstrated that MT contrast (MTC) can be highly sensitive to tissue collagen concentration, the primary component of desmoplasia. Thus, we hypothesized that desmoplasia-associated fibrosis levels in PDAC may be directly reflected in MT-MRI magnetization transfer ratio (MTR) measurements. The purpose of this study was to compare non-invasive MTR measurements to invasive histologic assessments of tumor fibrosis-levels in three mouse xenograft models of PDAC. In this study, MT MRI measurements were performed in 3 PDAC mouse xenograft models. For each of 28 PDAC xenografts, MTR were calculated and compared to histologic fibrosis levels from reference standard trichrome staining. MTR was found to be significantly higher in tumors grown using BxPC-3 cell line (39.4 ± 5.1, mean ± SD) compared to the MTR for the tumors grown from Panc-1 (32.4 ± 2.8) and Capan-1 (27.3 ± 2.9) cell lines (P < 0.05 for each comparison). Histologic measurements showed a similar trend with BxPC-3 tumors demonstrating significantly higher fibrosis levels (percentage of fibrotic tissue area, 6.48 ± 2.59) when compared to Panc-1 (3.54 ± 2.18) and Capan-1 (2.07 ± 1.60) tumors. MTR measurements were well correlated to quantitative fibrosis levels (r = 0.69, P = 0.01). Our results indicated that MTR measurements offer the potential to serve as a valuable in vivo biomarker of desmoplasia in PDAC. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1326. doi:1538-7445.AM2012-1326